CBAN vs NRIM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 18, 2026

CBAN

60.5
AI Score
VS
NRIM Wins

NRIM

61.5
AI Score

Investment Advisor Scores

CBAN

61score
Recommendation
BUY

NRIM

62score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBAN NRIM Winner
Net Income 8.20M 20.00M NRIM
ROE 2.2% 9.7% NRIM
ROA 0.2% 1.3% NRIM
Total Assets 3.72B 1.50B CBAN
Cash 104.09M 77.54M CBAN
Debt/Equity 0.68 0.20 NRIM
Free Cash Flow 53.83M 21.64M CBAN

Relative Price Performance (Last 90 Days)

CBAN 1M: +8.4% · 3M: +10.5% NRIM 1M: +0.5% · 3M: +10.2%

Current Technical Phase

CBAN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 61

RSI (14): 61.2 · Price: $21.92

NRIM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.6% over 20 days), RSI 54

RSI (14): 53.8 · Price: $27.25

Fundamentals Snapshot

Metric CBAN NRIM
Market Cap
Forward P/E 9.3 10.1
Trailing P/E 13.2 8.7
Revenue (TTM)
Revenue Growth 0.3% 0.1%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.4%
EPS 1.66 3.04
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, NRIM is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.